A new study published in the journal of Medicine showed that both linagliptin and dapagliflozin have good safety profiles and ...
Although both sodium-glucose cotransporter-2 inhibitors (SGLT2is) and glucagon-like peptide-1 receptor agonists (GLP-1 RAs) ...
Across studies, CKD was consistently associated with elevated cardiovascular risk, even after adjustment for traditional ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results